期刊文献+

辛伐他汀联合灯盏花素治疗糖尿病足疗效观察

下载PDF
导出
摘要 目的探讨辛伐他汀联合灯盏花素治疗糖尿病足(DF)临床疗效。方法将入选病例随机分为对照组26例和治疗组26例,对照组给予前列腺素E1静脉滴注,治疗组给予辛伐他汀片口服,灯盏花素静脉滴注,连续治疗4周。结果治疗组优于对照组,治疗组总有效率为84.6%(22例),治愈率为65.4%(17例),对照组总有效率80.8%(21例),治愈率为23.1%(6例),两组总疗效比较差异无统计学意义(P>0.05),治愈率差异有统计学意义(P<0.01)。结论辛伐他汀联合灯盏花素对DF的治疗有较好的临床疗效。
出处 《中国实用医药》 2009年第31期140-141,共2页 China Practical Medicine
  • 相关文献

参考文献1

二级参考文献18

  • 1刘沁,周哲慧,樊雨良,倪兆慧.氟伐他汀对蛋白尿的影响[J].中国中西医结合肾病杂志,2005,6(8):478-479. 被引量:14
  • 2Deakin S,Leviev I,Guernier S,et al.Simvastatin modulates expression of the PONI gene and increases serum paraoxonase:a role for sterol regulatory element-binding protein-2.Arterioscler Thromb Vasc Biol,2003,23:2083-2089.
  • 3Danesh FR,Sadeghi MM,Amro N,et al.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-indluced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway:Implications for diabetic nephropathy.Proc Natl Acad Sci US,2002,99:8301-8305.
  • 4Goppelt-struebe M,Halhn A,Iwanciw D,et al.Regulation of connective tissue growth factor (ccn 2 ; ctgf) gene expression in human mesangial cells:modulation by HMG-CoA reductase inhibitors(statins).Mol Pathol,2001,54:176-179.
  • 5Yang T,Chen JW,Liu CP.Combination of simvastatin and cilazapril have preventive effect on diabetic nephropathy in diabetic rat and cultured mesangial cells.Diabetologia,2001,44(suppl):A 265.
  • 6Sunekawa T,Hayash i T,Kano H,et al.Cerivastatin,ahydroxymethylglutaryl coenzyme a reductase inhibitor,improves endothelial function in elderly diabetic patients with in 3 days.Circulation,2001,104:376-379.
  • 7Lopez S,Peiretti F,Bonardo B,et al.Effect of atorvastatin on plasminogen activator in hibitor type-1 synthesis in human monocytes/macrophages.J Cardiovasc Pharmacol,2001,37:762-768.
  • 8Werner N,Nickenig G,Laufs U.Pleiotropic effects of HMGCoA reductase inhibitors.Basic Res Cardiol,2002,97:105-106.
  • 9Jone SP,Teshima Y,Akao M,et al.Simvastatin attenuatas oxidant-induced mitochondrial dysfunction in cardiac myocytes.Circ Res,2003,93:697-699.
  • 10Baigent C,Landray M,Leaper C,et al.First United Kingdom Heart and Renal Protection (UK-HARP-I) study:biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.Am J Kidney Dis,2005,45:473-484.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部